Non-opioid pharmacologic treatment of chronic spinal cord injury-related pain

Abstract

Purpose: Spinal cord injury-related pain is often a severe debilitating condition that adversely affects the patient’s physical health, psychological wellbeing and quality of life. Opioid medications have historically been prescribed to this population with great frequency. As opioid abuse disorder becomes an ever-worsening public health issue, more attention must be placed upon non-opioid options. This paper reviews non-opioid medications to be considered when treating spinal cord injury-related pain. The pertinent literature is reviewed, and the advantages and pitfalls of various medication options are discussed in the complicated context of the individual with a spinal cord injury.

Methods: Peer-reviewed journal articles and medication package insert data are reviewed.

Results:. The non-opioid medications with the greatest evidence for efficacy in the treatment of chronic spinal cord injury-related pain are drawn from the antiepileptic drug and antidepressant categories though the specific selection must be nuanced to the particular individual patient. More research is required to understand the role of calcitonin, lithium, and marijuana in treating spinal cord injury-related pain.

Conclusions: The complex clinical situation of each individual patient must be weighed against the risks and benefits of each medication, as reviewed in this paper, to determine the ideal treatment strategy for chronic spinal cord injury-related pain.

Keywords:

• Chronic pain
• Pharmacology
• Spinal cord injury
• Substance-related disorders
• Gabapentin
• Neuropathic pain

Disclaimer statements

Contributors None.

Funding None.

Conflicts of interest There are no conflicts of interest or financial interests to disclose by the authors.

Correction Statement

This article has been republished with minor changes. These changes do not impact the academic content of the article.